動物用血漿製品・誘導体市場：誘導体タイプ別、動物タイプ別-2025-2030年の世界予測

動物用血漿製品・誘導体市場は、2023年に7億5,259万米ドルと評価され、2024年には7億9,511万米ドルに達すると予測され、CAGR 5.76％で成長し、2030年には11億1,433万米ドルに達すると予測されています。

動物血液血漿製品および誘導体市場の範囲には、血漿、免疫グロブリン、アルブミンなど、動物の血液に由来するさまざまな製品が含まれます。これらの製品は、ペットフードの栄養成分の強化、家畜用飼料の結合剤としての役割、ワクチンや治療用タンパク質を製造するための医薬品の重要な成分としての役割のために不可欠です。市場の最終用途分野は多岐にわたり、ペットフード業界、家畜飼料メーカー、製薬会社からの需要が大きいです。主な成長要因としては、タンパク質が豊富な動物用飼料への需要の高まり、ペットの健康と高度な獣医学的ケアへの注目の高まり、効果的な生物製剤と治療薬に対する製薬業界のニーズなどが挙げられます。最近のビジネスチャンスは、収量と品質を向上させる革新的な加工技術の開発や、畜産・ペット産業が成長する新興国市場への進出にあります。しかし、動物の屠殺をめぐる倫理的懸念、規制上の障壁、高い加工コストなどの課題が、市場成長の限界となっています。技術革新は、持続可能な採血プロセス、合成代替品の開発、血漿誘導体の機能特性の改良に焦点を当て、用途を広げることにより、これらの課題に対処できる可能性があります。市場関係者への提言としては、持続可能でコスト効率の高い生産技術の研究開発に投資すること、天然で高タンパクな動物性食品を求める傾向が強まっていることを利用することなどが挙げられます。規制当局と協力してコンプライアンスを緩和することも、市場の可能性を引き出すことにつながります。市場は競合情勢が激しくダイナミックであり、急速な技術進歩と進化する規制状況を特徴とし、大陸をまたいで広大な存在感を示しています。継続的な技術革新と新たな消費者の嗜好への適応が、この領域で成功するための鍵となると思われます。全体として、この市場は、内在する課題にもかかわらず、市場の要求と倫理基準に沿ったイノベーションを取り入れることによって、成長のための複数の道を示しています。

市場力学：急速に進化する動物用血漿製品・誘導体市場の主要市場インサイトを公開

動物用血漿製品・誘導体市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 動物医療業界における動物血漿の利用拡大
  • 人口増加に伴う動物肉およびタンパク質需要の増加
• 市場抑制要因
  • 動物用血漿製品の安全性と品質基準に関する厳しい規制
• 市場機会
  • 動物用血漿製品の品質向上のためのバイオテクノロジーと加工技術における継続的な技術革新
  • 栄養補助食品と機能性食品の消費の増加
• 市場の課題
  • 動物血漿製品に代わる合成品の入手可能性

ポーターの5つの力：動物用血漿製品・誘導体市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用血漿製品・誘導体市場における外部からの影響の把握

外部マクロ環境要因は、動物用血漿製品・誘導体市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用血漿製品・誘導体市場における競合情勢の把握

動物用血漿製品・誘導体市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用血漿製品・誘導体市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用血漿製品・誘導体市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用血漿製品・誘導体市場における成功への道筋を描く

動物用血漿製品・誘導体市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 獣医医療業界における動物血漿の利用拡大
    • 人間の間で動物の肉とタンパク質に対する需要が高まっている
  • 抑制要因
    • 動物血漿製品の安全性と品質基準に関する厳格な規制
  • 機会
    • 動物血漿製品の品質向上に向けたバイオテクノロジーと加工技術の継続的な革新
    • 栄養補助食品や機能性食品の消費増加
  • 課題
    • 動物血漿製品の合成代替品の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用血漿製品・誘導体市場デリバティブの種類別

• ウシ胎児血清
• フィブリノーゲン
• 免疫グロブリン
• 血清アルブミン

第7章 動物用血漿製品・誘導体市場動物の種類別

• 牛
• 羊

第8章 南北アメリカの動物用血漿製品・誘導体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の動物用血漿製品・誘導体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの動物用血漿製品・誘導体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ACROBiosystems Inc.
• Alfa Laval Corporate AB
• ANZCO Foods Limited
• Auckland BioSciences Ltd.
• BioChemed Services
• Biowest Company
• Canvax Reagents S.L.
• Ebrator Biochemicals Inc.
• Kraeber & Co. GmbH
• Lake Immunogenics, Inc.
• LAMPIRE Biological Laboratories, Inc.
• Meiji Holdings Co., Ltd.
• Merck KGaA
• Moregate Biotech
• Pel-Freez, LLC
• Rockland Immunochemicals, Inc.
• Scripps Laboratories, Inc.
• TCS Biosciences Ltd.

LIST OF FIGURES

• FIGURE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVES TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Blood Plasma Products & Derivatives Market was valued at USD 752.59 million in 2023, expected to reach USD 795.11 million in 2024, and is projected to grow at a CAGR of 5.76%, to USD 1,114.33 million by 2030.

The scope of the animal blood plasma products and derivatives market encompasses a range of products derived from animal blood, including plasma, immunoglobulins, and albumins, which are crucial for various applications across sectors. These products are essential due to their role in enhancing the nutritional content of pet foods, serving as binders in feed for livestock, and being a vital ingredient in pharmaceuticals for producing vaccines and therapeutic proteins. The market's end-use sectors are varied, with significant demand from the pet food industry, livestock feed manufacturers, and pharmaceutical companies. Key growth factors include the rising demand for protein-rich animal diets, increasing focus on pet health and advanced veterinary care, and the pharmaceutical industry's need for effective biologics and cures. Recent opportunities lie in developing innovative processing techniques to improve yield and quality, and in expanding into emerging markets where livestock and pet industries are growing. However, challenges such as the ethical concerns surrounding animal slaughter, regulatory barriers, and high processing costs pose limitations to market growth. Innovation could potentially address these challenges by focusing on sustainable blood collection processes, developing synthetic alternatives, and improving the functional characteristics of plasma derivatives to broaden applications. Recommendations for market players include investing in R&D for sustainable and cost-efficient production techniques and capitalizing on the growing trend towards natural and high-protein animal products. Collaborating with regulatory bodies to ease compliance can also unlock market potential. The market is competitive and dynamic, with a sprawling presence across continents, characterized by rapid technological advancements and an evolving regulatory landscape. Continuous innovation and adaptation to emerging consumer preferences will be key to thriving in this domain. Overall, the market presents multiple avenues for growth, despite the inherent challenges, by embracing innovations that align with market demands and ethical standards.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Blood Plasma Products & Derivatives Market

The Animal Blood Plasma Products & Derivatives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing utilization of animal blood plasma in veterinary care industry
  • Rising demand for animal meat and protein among human population
• Market Restraints
  • Stringent regulations for safety and quality standards for animal blood plasma products
• Market Opportunities
  • Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
  • Increasing consumption of nutraceuticals and functional foods
• Market Challenges
  • Availability of synthetic alternatives to animal blood plasma products

Porter's Five Forces: A Strategic Tool for Navigating the Animal Blood Plasma Products & Derivatives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Blood Plasma Products & Derivatives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Blood Plasma Products & Derivatives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Blood Plasma Products & Derivatives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Blood Plasma Products & Derivatives Market

A detailed market share analysis in the Animal Blood Plasma Products & Derivatives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Blood Plasma Products & Derivatives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Blood Plasma Products & Derivatives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Blood Plasma Products & Derivatives Market

A strategic analysis of the Animal Blood Plasma Products & Derivatives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Moregate Biotech, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Scripps Laboratories, Inc., and TCS Biosciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Animal Blood Plasma Products & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Derivatives Type, market is studied across Fetal Bovine Serum, Fibrinogen, Immunoglobulin, and Serum Albumin.
• Based on Animal Type, market is studied across Bovine and Ovine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing utilization of animal blood plasma in veterinary care industry
    • 5.1.1.2. Rising demand for animal meat and protein among human population
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations for safety and quality standards for animal blood plasma products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
    • 5.1.3.2. Increasing consumption of nutraceuticals and functional foods
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of synthetic alternatives to animal blood plasma products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Blood Plasma Products & Derivatives Market, by Derivatives Type

• 6.1. Introduction
• 6.2. Fetal Bovine Serum
• 6.3. Fibrinogen
• 6.4. Immunoglobulin
• 6.5. Serum Albumin

7. Animal Blood Plasma Products & Derivatives Market, by Animal Type

• 7.1. Introduction
• 7.2. Bovine
• 7.3. Ovine

8. Americas Animal Blood Plasma Products & Derivatives Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Animal Blood Plasma Products & Derivatives Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACROBiosystems Inc.
• 2. Alfa Laval Corporate AB
• 3. ANZCO Foods Limited
• 4. Auckland BioSciences Ltd.
• 5. BioChemed Services
• 6. Biowest Company
• 7. Canvax Reagents S.L.
• 8. Ebrator Biochemicals Inc.
• 9. Kraeber & Co. GmbH
• 10. Lake Immunogenics, Inc.
• 11. LAMPIRE Biological Laboratories, Inc.
• 12. Meiji Holdings Co., Ltd.
• 13. Merck KGaA
• 14. Moregate Biotech
• 15. Pel-Freez, LLC
• 16. Rockland Immunochemicals, Inc.
• 17. Scripps Laboratories, Inc.
• 18. TCS Biosciences Ltd.